Paper3989296
Natural killer (NK) cells are present in mice with severe combined immunodeficiency (scid).
Dorshkind K and 3 others. J Immunol, 1985. Cited by 373 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Natural killer (NK) cells are present in mice with severe combined immunodeficiency (scid). Papers, record 3989296. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3989296
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cytotoxicity, Immunologic | Major topic |
| G(M1) Ganglioside | Major topic |
| Immunologic Deficiency Syndromes | Major topic |
| Killer Cells, Natural | Major topic |
| Mice, Mutant Strains | Major topic |
| Animals | |
| Antibodies, Monoclonal | |
| Glycosphingolipids | |
| Isoantibodies | |
| Lymphoma | |
| Mice | |
| Phenotype | |
| Spleen |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| A121256-01 | PHS HHS | United States | PubMed | PubMed | |
| AI13323 | NIAID NIH HHS | United States | R01AI013323 | PubMed and NIH | NIH RePORTER |
| CA04946 | NCI NIH HHS | United States | R01CA004946 | PubMed and NIH | NIH RePORTER |
| R37CA004946 | NIH | NIH RePORTER |
Cited by126
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 373 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41655129 | Overactivation of Cdc42 GTPase Impairs the Cytotoxic Function of NK Cells From Old Individuals Towards Senescent Fibroblasts. | Aging Cell | 2026 | https://conductscience.org/library/papers/41655129 | PubMed |
| 41064357 | Prolactin and DNA damage trigger an anti-breast cancer cell immune response. | Front Endocrinol (Lausanne) | 2025 | https://conductscience.org/library/papers/41064357 | PubMed |
| 40119461 | Curative timed NK cell-based immunochemotherapy aborts brain tumour recurrence driven by mesenchymal glioma stem cells. | Acta Neuropathol Commun | 2025 | https://conductscience.org/library/papers/40119461 | PubMed |
| 38731936 | Tinostamustine (EDO-S101), an Alkylating Deacetylase Inhibitor, Enhances the Efficacy of Daratumumab in Multiple Myeloma by Upregulation of CD38 and NKG2D Ligands. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38731936 | PubMed |
| 38436833 | Comprehensive Insight into the Functional Roles of NK and NKT Cells in HTLV-1-Associated Diseases and Asymptomatic Carriers. | Mol Neurobiol | 2024 | https://conductscience.org/library/papers/38436833 | PubMed |
| 37511495 | Mouse Models for HTLV-1 Infection and Adult T Cell Leukemia. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37511495 | PubMed |
| 37221140 | Transplantation of Human Brain-Derived Ischemia-Induced Multipotent Stem Cells Ameliorates Neurological Dysfunction in Mice After Stroke. | Stem Cells Transl Med | 2023 | https://conductscience.org/library/papers/37221140 | PubMed |
| 35874055 | Comparison between intratumoral and intravenously administered oncolytic virus therapy with Newcastle disease virus in a xenograft murine model for pancreatic adenocarcinoma. | Heliyon | 2022 | https://conductscience.org/library/papers/35874055 | PubMed |
| 34805408 | Reevaluation of NOD/SCID Mice as NK Cell-Deficient Models. | Biomed Res Int | 2021 | https://conductscience.org/library/papers/34805408 | PubMed |
| 34370181 | Translational Development of a Zr-89-Labeled Inhibitor of Prostate-specific Membrane Antigen for PET Imaging in Prostate Cancer. | Mol Imaging Biol | 2022 | https://conductscience.org/library/papers/34370181 | PubMed |
| 32456018 | Patient-Derived Xenograft Models of Pancreatic Cancer: Overview and Comparison with Other Types of Models. | Cancers (Basel) | 2020 | https://conductscience.org/library/papers/32456018 | PubMed |
| 31619256 | NANOG helps cancer cells escape NK cell attack by downregulating ICAM1 during tumorigenesis. | J Exp Clin Cancer Res | 2019 | https://conductscience.org/library/papers/31619256 | PubMed |
| 30781517 | The TLR3 Agonist Poly Inosinic:Cytidylic Acid Significantly Augments the Therapeutic Activity of an Anti-CD7 Immunotoxin for Human T-cell Leukaemia. | Biomedicines | 2019 | https://conductscience.org/library/papers/30781517 | PubMed |
| 30288966 | Strain-specific metastatic phenotypes in pheochromocytoma allograft mice | Endocr Relat Cancer | 2018 | https://conductscience.org/library/papers/30288966 | PubMed |
| 29786784 | Generation of Prostate Cancer Patient-Derived Xenografts to Investigate Mechanisms of Novel Treatments and Treatment Resistance. | Methods Mol Biol | 2018 | https://conductscience.org/library/papers/29786784 | PubMed |
| 29594927 | Differences between immunodeficient mice generated by classical gene targeting and CRISPR/Cas9-mediated gene knockout. | Transgenic Res | 2018 | https://conductscience.org/library/papers/29594927 | PubMed |
| 27662655 | NSG Mice Provide a Better Spontaneous Model of Breast Cancer Metastasis than Athymic (Nude) Mice. | PLoS One | 2016 | https://conductscience.org/library/papers/27662655 | PubMed |
| 27489678 | Spontaneous development of neoplasms in severe combined immunodeficient mice. | SAGE Open Med Case Rep | 2015 | https://conductscience.org/library/papers/27489678 | PubMed |
| 26284063 | NK Cell-Mediated Antibody-Dependent Cellular Cytotoxicity in Cancer Immunotherapy. | Front Immunol | 2015 | https://conductscience.org/library/papers/26284063 | PubMed |
| 26137412 | Natural Killer cell control of BRAFV600E mutant melanoma during targeted therapy. | Oncoimmunology | 2015 | https://conductscience.org/library/papers/26137412 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3989296
GET https://conductscience.org/api/papers/v1/3989296/cited_by?page=2